QQ客服 官方微博 反馈留言

	A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma-the ESO-shanghai 1 trial protocol
	Chen, Yun; Zhu, Zhengfei; Zhao, Weixin; Li, Ling; Ye, Jinjun; Wu, Chaoyang; Tang, Huarong; Lin, Qin; Li, Jiancheng; Xia, Yi
刊名	RADIATION ONCOLOGY
	2018
卷号	13
关键词	Esophageal squamous cell carcinoma Concurrent chemoradiotherapy Paclitaxel Cisplatin 5-fluorouracil
ISSN号	1748-717X
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3603543
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Chen, Yun,Zhu, Zhengfei,Zhao, Weixin,et al. A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma-the ESO-shanghai 1 trial protocol[J]. RADIATION ONCOLOGY,2018,13.
APA	Chen, Yun.,Zhu, Zhengfei.,Zhao, Weixin.,Li, Ling.,Ye, Jinjun.,...&Zhao, Kuaile.(2018).A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma-the ESO-shanghai 1 trial protocol.RADIATION ONCOLOGY,13.
MLA	Chen, Yun,et al."A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma-the ESO-shanghai 1 trial protocol".RADIATION ONCOLOGY 13(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。